Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lavinia Rech has a total of 189 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cytomegalovirus Latency Fuels Inflammation Following Myocardial Infarction

    by Eleni Dapergola, Marko Šustić, DiyaaElDin Ashour, Ebram Tharwat Melika, Maja Cokarić Brdovčak, Jelena Materljan Franki, Mijo Golemac, Berislav Lisnić, Ema Bellulovich, Valérie Boivin-Jahns, et al.

    BACKGROUND: Epidemiological studies have consistently associated cytomegalovirus (CMV) seropositivity with adverse cardiovascular outcomes. However, the mechanisms by which cytomegalovirus infection impacts pathophysiology in the heart remain poorly understood. In this study, we sought to dissect how latent murine cytomegalovirus infection impacts cardiac immune cell dynamics at steady-state and during postmyocardial infarction (MI) repair. METHODS: Experimental MI studies were conducted in C57BL/6J mice previously infected with murine cytomegalovirus. In situ inflammatory responses were characterized by spectral flow cytometry, bulk and single-cell RNA/T-cell receptor (TCR) sequencing, whereas cardiac function was monitored by echocardiography and cardiac magnetic resonance imaging. Moreover, we retrospectively assessed the cytomegalovirus serostatus and associated T-cell expansions in a well-characterized patient cohort with longitudinal cardiac magnetic resonance imaging data available and performed bulk TCR sequencing on peripheral blood and myocardial samples to identify cytomegalovirus-specific TCRs. RESULTS: Our findings show that exposure to murine cytomegalovirus induces long-term changes in the cardiac transcriptional profile and alterations in various cardiac-resident immune cell populations, including the establishment of virus-specific memory CD8 + T-cell residency. Compared with infarcted controls, mice previously exposed to murine cytomegalovirus exhibited stronger inflammatory responses marked by increased CD8 + T-cell infiltration and worsened cardiac function following MI. These observations in mice were supported by data from patients with cytomegalovirus seropositive MI, who harbored cytomegalovirus-responsive T cells in the heart. CONCLUSIONS: Our findings demonstrate that latent cytomegalovirus infection leads to long-term changes in the cardiac microenvironment, which ultimately impair post-MI healing outcomes.


  • Open Access

    From Automated ECG Interpretation to Multimodal Cardiovascular Intelligence: The Evolution of Artificial Intelligence in Cardiovascular Medicine

    by Lavinia Rech

    Artificial intelligence (AI) is rapidly transforming cardiovascular medicine, driven by the increasing availability of large-scale clinical data and advances in machine learning. Early computational applications in cardiology were primarily limited to rule-based electrocardiogram interpretation systems. Over time, these approaches have evolved into sophisticated deep learning models capable of analysing complex cardiovascular signals and imaging data. In parallel with the broader development of digital health technologies, including wearable devices, electronic health records, and remote monitoring systems, AI applications have expanded across multiple domains of cardiovascular care. These now include electrocardiographic (ECG) and electrophysiological analysis, cardiovascular imaging, surgical planning, and multimodal risk prediction. More recently, multimodal AI models have emerged that integrate heterogeneous data sources such as imaging, physiological signals, clinical records, and genomic information, enabling more comprehensive characterisation of cardiovascular disease. Beyond diagnostic applications, AI is increasingly influencing system-level aspects of cardiovascular medicine, including clinical decision support, workflow optimisation, medical education, and clinical trial design. This narrative review traces the historical and clinical evolution of artificial intelligence in cardiovascular medicine from early automated ECG interpretation systems to contemporary multimodal and system-level applications. It highlights key technological developments, current clinical applications, translational challenges, and the emerging role of AI within digital cardiovascular health ecosystems, with particular emphasis on early disease detection, risk stratification, prognostic modelling, and personalised cardiovascular care.


  • Open Access

    Perspective Chapter: Heart Failure Beyond the Heart – Neuroimmune Cytokine Signalling in Cardiac Remodelling and Systemic Disease Progression

    by Lavinia Rech

    Heart failure is clinically defined by cardiac dysfunction, haemodynamic congestion, ventricular remodelling and neurohormonal activation, yet its patient-centred manifestations often extend beyond these domains. Fatigue, frailty, cognitive vulnerability, mood disturbance, sleep disruption, and reduced resilience are only partially explained by conventional cardiac measurements. This chapter examines heart failure as a cytokine-mediated heart–brain–immune syndrome in which cardiac, immune, vascular, metabolic, autonomic, behavioural and central nervous system pathways interact over time. It briefly summarises the major cytokine networks involved in heart failure, including tumour necrosis factor-α, interleukin-1β, interleukin-6, chemokines, inflammasome-related mediators, adipokines, and stress-responsive cytokine-like molecules. It then develops a heart–brain–immune framework in which cytokines function not only as biomarkers of disease severity but also as regulatory mediators that link myocardial stress, endothelial dysfunction, autonomic imbalance, sleep disruption, skeletal muscle vulnerability, cognitive and affective regulation, frailty, and recurrent decompensation. Within this model, symptoms are not merely consequences of haemodynamic impairment; they also become mechanisms that reinforce inflammatory activation, reduce resilience, and contribute to disease progression. The chapter further proposes clinically recognisable dimensions of neuroimmune vulnerability and discusses translational implications for biomarker interpretation, phenotype-guided therapy, longitudinal monitoring, and mechanism-based trials. Recognising heart failure as a cytokine-mediated heart–brain–immune network helps explain symptom–haemodynamic discordance and supports more precise, patient-centred approaches to disease classification, monitoring, and treatment.

  • Open Access

    C-Reactive Protein and Incident Chronic Pain in Older Adults: Comorbidity-Driven Risk Profiles and Implications for Preventive Screening

    by Lavinia Rech, Justyna Garnier, Anny Chin, Gustavo Mucci, Mariana Póvoa-Corrêa, Renata Moll-Bernardes, Vitor Y. Yonekura, Waynice N. Paula-Garcia, Felipe Fregni, Kevin Pacheco-Barrios

    • 11 July 2026
      • p. 106376

    C-Reactive Protein and Incident Chronic Pain in Older Adults: Comorbidity-Driven Risk Profiles and Implications for Preventive Screening.

    by Lavinia Rech, Justyna Garnier, Anny Chin, Gustavo Mucci, Mariana Póvoa-Corrêa, Renata Moll-Bernardes, Vitor Y Yonekura, Waynice N Paula-Garcia, Felipe Fregni, Kevin Pacheco-Barrios

    Systemic inflammatory biomarkers such as C-reactive protein (CRP) and interleukin-6 (IL-6) have been implicated in chronic pain, but their independent predictive role in older adults remains unclear. Using longitudinal data from the Health and Retirement Study (2016-2022), we analysed 1,850 older adults without chronic pain or arthritis at baseline. CRP, IL-6, IL-10, IGF-1, and the composite INFLA-score, a composite index of low-grade systemic inflammation, were assessed as exposures. Incident chronic pain was defined as the first report of pain during follow-up. Population-averaged Poisson regression models with robust standard errors were used, and sensitivity analyses were conducted in a broader cohort including participants with baseline arthritis. After multivariable adjustment, CRP remained independently associated with incident chronic pain (incidence rate ratio [IRR] 1.10, 95% CI 1.01-1.20), although the effect size was modest. Depression (IRR 1.52, 95% CI 1.23-1.88) and body mass index (IRR 1.02 per unit, 95% CI 1.01-1.04) were stronger predictors. IL-6 was not independently associated in the arthritis-free cohort but showed a small effect in the broader cohort, suggesting context-dependent associations. Incorporating CRP into a clinical prediction model yielded minimal improvement in discrimination (ΔAUC +0.009). IGF-1 showed an inverse association with chronic pain risk in participants without arthritis or obesity. Overall, systemic inflammatory biomarkers appear to contribute limited independent predictive value, while comorbidity burden and psychosocial factors dominate risk. PERSPECTIVE: This study shows that commonly used inflammatory biomarkers offer limited incremental value in predicting chronic pain among older adults. Instead, depression and metabolic factors are the dominant risk factors, supporting a shift towards clinically integrated risk stratification rather than biomarker-based screening alone.

  • Open Access

    Cytomegalovirus latency exacerbates cardiac inflammation and tissue remodeling after myocardial infarction

    by Eleni Dapergola, Marko Šustić, Diyaa ElDin Ashour, Maja Cokarić Brdovčak, Jelena Materljan Franki, Mijo Golemac, Berislav Lisnić, Valèrie Boivin-Jahns, Tobias Krammer, Kenz Le Gouge, et al.

    Background: Epidemiological studies have consistently associated cytomegalovirus (CMV) seropositivity with adverse cardiovascular outcomes. However, the mechanisms by which CMV infection impacts pathophysiological mechanisms in the heart remain poorly understood. In this study, we sought to dissect how latent murine CMV infection impacts cardiac immune cell dynamics at steady-state and during post-myocardial infarction (MI) repair. Methods: Experimental MI studies were conducted in C57BL/6J mice previously infected with murine CMV (MCMV). In situ inflammatory responses were characterized by spectral flow cytometry, bulk and single-cell RNA / T cell receptor sequencing, whereas cardiac function was monitored by echocardiography and magnetic resonance imaging (cMRI). Moreover, we retrospectively assessed the CMV serostatus in a well-characterized patient cohort with longitudinal cMRI data available and performed bulk T cell receptor sequencing on peripheral blood and myocardial samples to identify CMV-specific TCRs. Results: Our findings show that exposure to MCMV induces long-term changes in the cardiac transcriptional profile and alterations in cardiac-resident immune cell populations, including the establishment of virus-specific memory CD8 + T cell residency. Compared to infarcted controls, mice previously exposed to MCMV exhibited stronger inflammatory responses, marked by increased CD8 + T cell infiltration, and worsened cardiac function following MI. These observations in mice were supported by data from CMV-seropositive MI patients, who harbored CMV-responsive T cells in the heart. Conclusions: Our findings demonstrate that latent CMV infection leads to long-term changes in the cardiac microenvironment, which ultimately impair post-MI healing outcomes.


  • Open Access

    Preclinical Assessment of Atorvastatin for Treatment of Endocardial Fibroelastosis

    by Daniel Diaz-Gil, Gregor Gierlinger, Natalia Silva-Gomez, Lavinia Rech, Jesus Ortiz-Urbina, Kerstin Saraci, Sophia Koutsogiannaki, Cordula M. Wolf, Rainer G. Kozlik-Feldmann, Rudolf Mair, et al.


  • Open Access

    MAGNITUDE: Transcranial Magnetic Stimulation for Treatment-Resistant Obsessive–Compulsive Disorder: A Randomized Sham-Controlled Phase II Trial Protocol

    by Lavinia Rech, Ricardo A. Vivanco, Ana Claudia Guersoni, Gianina M. Crisóstmono Ninapaytan, Paulina Bonilla Rivera, Elisabeth J. Ramos-Orosco, Ariana Vargas-Ruiz, Martha Felipe, Sandra Carvalho

    Obsessive–Compulsive Disorder (OCD) is a chronic psychiatric condition with a lifetime prevalence of 2–3%. It significantly burdens quality of life and is associated with substantial economic and disease burdens. Cognitive-behavioral therapy and high-dose selective serotonin reuptake inhibitors are considered the first-line treatments for OCD. Approximately two-thirds of patients with Obsessive–Compulsive Disorder (OCD) exhibit inadequate responses to current standard therapies, thus lacking adequate therapy, resulting in a loss of quality of life and huge economic burdens. Repetitive transcranial stimulation (rTMS) is a non-invasive, safe, and well-tolerated intervention that modulates prefrontal cortical circuits involved in OCD. A previous systematic review explored the therapeutic effects of rTMS applied to the dorsolateral prefrontal cortex (dlPFC) area in patients with treatment-resistant OCD. It showed that the application of high-frequency and low-frequency (LF) rTMS to the dlPFC region yielded controversial post-treatment Y-BOCS (Yale-Brown Obsessive–Compulsive Scale) findings due to factors such as small sample sizes, short-term study durations, and variations in rTMS protocols. Objectives: Thus, we propose a theoretical protocol based on previous findings to assess better the effect of LF rTMS for treatment-resistant OCD patients. Methods: We will recruit patients with moderate to severe OCD and limited response to previous treatments from in- and outpatient clinics. We will use fMRI for precious localization of the right dlPFC and application of 1 Hz stimulation of in total 2000 pulses with three times 40 s inter-train intervals 5 days a week, in 6 consecutive weeks. The primary outcome will be the mean reduction in Y-BOCS at the end of this study. Conclusions: This study highlights rTMS’s potential to reform OCD treatment, accentuate safety, accessibility, clinical integration, and future research foundations.


  • Open Access

    A distinct T cell receptor signature associates with cardiac outcome in myocardial infarction patients

    by Kenz Le Gouge, DiyaaElDin Ashour, Margarete Heinrichs, Paul Stys, Pierre Barennes, Verena Stangl, Lavinia Rech, Gerald Hoefler, Karl Kashofer, Tobias Gassenmaier, et al.

    Myocardial infarction (MI) is associated with an inflammatory process mainly attributed to innate immune components. Very recently, the role of T-cells in both inflammation and healing has been suggested through various human and mouse studies. Previous studies showed that CD4+ and CD8+ T cells affect post-MI repair but did not investigate how to leverage T cell biology to predict post-MI outcomes in patients. For instance, the antigenic trigger of T-cells is still unknown in human. Indeed, others and we identified T-cell specific for myosin infiltrating the myocardium in mouse models of MI, recent studies identified expanded clones in human myocardium, altogether suggesting a tissue-specific T-cell activation. However, it is still unclear how acute post-MI immune responses shape long-term cardiac functional outcomes in individual patients. In this study, we analyzed the role of T-cell in predicting post-MI repair by analyzing the T-cell receptor (TCR) repertoire. Indeed, the TCR repertoire is now considered as a marker of the clinical status of individuals. Previous studies in infectious but also autoimmune contexts showed the potential of the TCR repertoire to predict the disease. Therefore, assessing the dynamic changes in global TCR repertoires may provide valuable information about the antigen-specific immune responses underlying post-MI healing. In our study, we carefully selected patients that suffered from MI on a prospective cohort. The TCR repertoire has been analyzed by next generation sequencing at the index hospitalization with the aim to identify features predict of their healing outcome assessed at 12 months post-MI. While no major variations have been found in diversity of TCR gene usage, we identified unique TCR signatures predicting one-year cardiac functional outcomes. Our result enables early immune-based risk stratification of MI patients and calls for larger studies to develop novel predictive biomarkers and possibly new therapeutics.


  • Open Access

    Extracellular Matrix Protein-1 as a Mediator of Inflammation-Induced Fibrosis After Myocardial Infarction

    by Sean A. Hardy, Laura Liesinger, Ralph Patrick, Maria Poettler, Lavinia Rech, Juergen Gindlhuber, Nishani S. Mabotuwana, DiyaaEldin Ashour, Verena Stangl, Mark Bigland, et al.